RESUMO
Objective: It was to evaluate changes in lifestyle habits and health behavior among university students in Peru and Mexico during periods of confinement associated with the COVID-19 pandemic and to identify possible relationships between these changes and sociodemographic variables, health status, and technology consumption. Methods: It was a quantitative, observational, and cross-sectional study conducted among a population of 739 Mexican students and 305 Peruvian students, most of whom were women (n =778, 74.5%) and non-graduates (n =921, 88.2%). The questionnaire scale for changes in lifestyles during the quarantine period has been previously validated. Results: The association between sociodemographic factors and dimensions of change in healthy lifestyles was evaluated, and it was shown that gender and country of residence were significant for all dimensions of healthy lifestyle (p < 0.05), except for the level of education, which did not show significance about the change in the dimensions of media consumption (p = 0.875) and physical activity (p = 0.239). Within the dimensions mentioned, it can be stated that women are more likely than men to change their eating habits (adjusted prevalences (aPR) = 1.08, p < 0.001), media consumption (aPR = 1.04, p < 0.001), and physical activity (aPR = 1.02, p < 0.001). Meanwhile, participants from Peru are more likely than participants from Mexico to change physical activity (aPR = 1.14, p < 0.001) and media consumption (aPR = 1.22, p < 0.001). Finally, graduate students were more likely than undergraduate students to change eating habits (aPR = 1.09, p = 0.005) and unhealthy habits (aPR = 1.06, p = 0.030). Conclusion: It was concluded that there were lifestyle changes in Mexican and Peruvian university students in their eating habits, physical activity, internet consumption, and food delivery.
RESUMO
Introducción: La necrólisis epidérmica tóxica (NET) y el síndrome de Stevens-Johnson (SSJ) son reacciones cutáneas raras, graves y potencialmente mortales asociadas principalmente al uso de medicamentos; sin embargo, se ha señalado la posible relación entre el SSJ con la infección por Mycoplasma pneumoniae o herpes. El tratamiento consiste en la suspensión del fármaco y cuidados de soporte. No existe tratamiento específico que haya demostrado eficacia. Se ha propuesto el uso de inmunoglobulina intravenosa debido a su potencial anti-Fas in vitro, aunque sus efectos reportados no son concluyentes. Objetivo: Describir la respuesta a inmunoglobulina intravenosa en el tratamiento del SSJ/NET en el Hospital de Especialidades Centro Médico Nacional Siglo XXI. Material y métodos: Se realizó un estudio descriptivo retrospectivo en pacientes con SSJ/NET del servicio de Medicina Interna que recibieron inmunoglobulina intravenosa (IV) en el período de marzo de 2008 y abril de 2014. Resultados: Siete pacientes recibieron de 1-3 g/kg de inmunoglobulina IV, 5 mujeres (87.7%) y 1 hombre (14.2%). Todos se relacionaron con ingesta de fármacos, trimetoprim/sulfametoxazol en el 28.5% de los casos. El 71.4% presentó fiebre, 85.7% presentó afección mayor al 10% de la superficie corporal, 100% presentó afección de 2 o más mucosas y 42.8% requirió manejo avanzado de la vía aérea. La estancia hospitalaria promedio fue de 32 días. No ocurrieron defunciones. Una mujer presentó hipertensión asociada a la infusión de inmunoglobulina, así como cefalea, y otra paciente desarrolló neumonía nosocomial. Conclusiones: La respuesta a inmunoglobulina IV fue satisfactoria logrando abortar la progresión del cuadro en 5 pacientes, 85.7% de los casos, sin efectos adversos relevantes(AU)
Background: Toxic epidermal necrolysis (TEN) and Stevens -Johnson syndrome (SJS) are rare but serious and potentially lifethreatening adverse cutaneous drug reactions. However, a possible relationship between SJS with Mycoplasma pneumoniae infection or herpes has been noted. Treatment consists of drug discontinuation and supportive care as there is no specific therapy that has shown efficacy. Intravenous immunoglobulins have been tested as a consequence of the anti-Fas in vitro potential, although its reported effects are inconclusive. Objective: To describe the response to intravenous immunoglobulin in the management of SJS / TEN in Hospital de Especialidades Centro Médico Nacional SXXI. Material and methods: A retrospective descriptive study was conducted in patients with SJS / TEN in the service of Internal Medicine who received intravenous immunoglobulin (IVIG) from March 2008 until April 2014. Results: Seven patients received 1-3 g/ kg IV immunoglobulin, 5 females (87.7 %) and 1 male (14.2 %), all related to ingestion of drugs, trimethoprim/ sulfamethoxazole in 28.5 % of cases. 71.4% had fever, 85.7 % had skin involvement of greater than 10% of the body surface , 100 % had involvement of 2 or more mucous and 42.8 % required advanced airway management . The average hospital stay was 32 days. No deaths occurred. A woman has hypertension associated with immunoglobulin infusion and headache, and another patient developed nosocomial pneumonia Conclusions: Response to IV immunoglobulin was satisfactory as it was associated with cessation of skin and mucosal detachment in 85.7 % of cases without significant adverse effects.